CRANBURY, N.J., Aug. 27, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that 1 presentation and 4 posters related to its investigational pharmacological chaperones will be included at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2012. SSIEM 2012 will be held September 4-7, 2012 in Birmingham, United Kingdom.
